| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |